Atlas Trials

A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis

Clinical trial NCT01782339 · COMPLETED

Trial details

NCT number
NCT01782339
Sponsor
Barts & The London NHS Trust
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Germ Cell Tumour
Start date
2012-05-01
Primary completion
2021-05-05
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.